482 related articles for article (PubMed ID: 16534460)
1. Visual function in patients with choroidal neovascularization resulting from age-related macular degeneration: the importance of looking beyond visual acuity.
Fletcher DC; Schuchard RA
Optom Vis Sci; 2006 Mar; 83(3):178-89. PubMed ID: 16534460
[TBL] [Abstract][Full Text] [Related]
2. Health- and vision-related quality of life among patients with choroidal neovascularization secondary to age-related macular degeneration at enrollment in randomized trials of submacular surgery: SST report no. 4.
Dong LM; Childs AL; Mangione CM; Bass EB; Bressler NM; Hawkins BS; Marsh MJ; Miskala P; Jaffee HA; McCaffrey LA;
Am J Ophthalmol; 2004 Jul; 138(1):91-108. PubMed ID: 15234287
[TBL] [Abstract][Full Text] [Related]
3. Vision loss in younger patients: a review of choroidal neovascularization.
Miller DG; Singerman LJ
Optom Vis Sci; 2006 May; 83(5):316-25. PubMed ID: 16699445
[TBL] [Abstract][Full Text] [Related]
4. Vision-related quality of life in patients suffering from age-related macular degeneration.
Berdeaux GH; Nordmann JP; Colin E; Arnould B
Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
[TBL] [Abstract][Full Text] [Related]
5. Quality of life in patients with age-related macular degeneration: impact of the condition and benefits of treatment.
Slakter JS; Stur M
Surv Ophthalmol; 2005; 50(3):263-73. PubMed ID: 15850815
[TBL] [Abstract][Full Text] [Related]
6. Natural history of predominantly classic, minimally classic, and occult subgroups in exudative age-related macular degeneration.
Shah AR; Del Priore LV
Ophthalmology; 2009 Oct; 116(10):1901-7. PubMed ID: 19592101
[TBL] [Abstract][Full Text] [Related]
7. Prophylactic laser treatment appears to promote choroidal neovascularisation in high-risk ARM: results of an interim analysis.
Owens SL; Bunce C; Brannon AJ; Wormald R; Bird AC;
Eye (Lond); 2003 Jul; 17(5):623-7. PubMed ID: 12855972
[TBL] [Abstract][Full Text] [Related]
8. Twelve-month safety and visual acuity results from a feasibility study of intraocular, epiretinal radiation therapy for the treatment of subfoveal CNV secondary to AMD.
Avila MP; Farah ME; Santos A; Kapran Z; Duprat JP; Woodward BW; Nau J
Retina; 2009 Feb; 29(2):157-69. PubMed ID: 19202425
[TBL] [Abstract][Full Text] [Related]
9. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
Bandello F; Lafuma A; Berdeaux G
Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
[TBL] [Abstract][Full Text] [Related]
10. Reading performance with low-vision aids and vision-related quality of life after macular translocation surgery in patients with age-related macular degeneration.
Nguyen NX; Besch D; Bartz-Schmidt K; Gelisken F; Trauzettel-Klosinski S
Acta Ophthalmol Scand; 2007 Dec; 85(8):877-82. PubMed ID: 17651462
[TBL] [Abstract][Full Text] [Related]
11. Computerized model of cost-utility analysis for treatment of age-related macular degeneration.
Fletcher EC; Lade RJ; Adewoyin T; Chong NV
Ophthalmology; 2008 Dec; 115(12):2192-8. PubMed ID: 18930556
[TBL] [Abstract][Full Text] [Related]
12. Characteristics of choroidal neovascularization in the complications of age-related macular degeneration prevention trial.
Maguire MG; Alexander J; Fine SL;
Ophthalmology; 2008 Sep; 115(9):1468-73, 1473.e1-2. PubMed ID: 18486222
[TBL] [Abstract][Full Text] [Related]
13. Relationships between clinical measures of visual function, fluorescein angiographic and optical coherence tomography features in patients with subfoveal choroidal neovascularisation.
Moutray T; Alarbi M; Mahon G; Stevenson M; Chakravarthy U
Br J Ophthalmol; 2008 Mar; 92(3):361-4. PubMed ID: 18303157
[TBL] [Abstract][Full Text] [Related]
14. Transpupillary thermotherapy for the treatment of choroidal neovascularization in age-related macular degeneration in Taiwan.
Tsai TH; Yang CM; Yang CH; Ho TC; Huang JS; Chen MS
Eye (Lond); 2007 Jun; 21(6):721-6. PubMed ID: 16543926
[TBL] [Abstract][Full Text] [Related]
15. Transpupillary thermotherapy for the treatment of occult CNV in age-related macular degeneration: a prospective randomized controlled pilot study.
Myint K; Armbrecht AM; Mon S; Dhillon B
Acta Ophthalmol Scand; 2006 Jun; 84(3):328-32. PubMed ID: 16704693
[TBL] [Abstract][Full Text] [Related]
16. Preferential Hyperacuity Perimeter (PreView PHP) for detecting choroidal neovascularization study.
Alster Y; Bressler NM; Bressler SB; Brimacombe JA; Crompton RM; Duh YJ; Gabel VP; Heier JS; Ip MS; Loewenstein A; Packo KH; Stur M; Toaff T;
Ophthalmology; 2005 Oct; 112(10):1758-65. PubMed ID: 16154198
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the traveling vision examiner program in the submacular surgery trials pilot study.
Orr PR; Marsh MJ; Hawkins BS; Hawse PL; Bressler NM;
Ophthalmic Epidemiol; 2005 Feb; 12(1):47-57. PubMed ID: 15848920
[TBL] [Abstract][Full Text] [Related]
18. Clinical impairment measures and reading performance in a large age-related macular degeneration group.
Cacho I; Dickinson CM; Smith HJ; Harper RA
Optom Vis Sci; 2010 May; 87(5):344-9. PubMed ID: 20386356
[TBL] [Abstract][Full Text] [Related]
19. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).
Abbott EJ; Connor GB; Artes PH; Abadi RV
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1416-23. PubMed ID: 17325191
[TBL] [Abstract][Full Text] [Related]
20. A comparison of macular translocation with patch graft in neovascular age-related macular degeneration.
Chen FK; Patel PJ; Uppal GS; Rubin GS; Coffey PJ; Aylward GW; Da Cruz L
Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1848-55. PubMed ID: 19060287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
